Skip to main content
Watch Insiders

Corporate insider profile

Harold Bernstein Insider Trades

Latest reported as President, R&D & CMO of Maze Therapeutics, Inc. (MAZE).

Purchase filings
0
Reported companies
1
Net open-market value
-$3,041,819.65
Latest transaction
Oct 1, 2026

Affiliated corporations

Reported company relationships

MAZELatest reported

Maze Therapeutics, Inc.

President, R&D & CMO

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Oct 1, 2026Maze Therapeutics, Inc. (MAZE)President, R&D & CMOSale16,141$26.93$434,743
Sep 4, 2026Maze Therapeutics, Inc. (MAZE)President, R&D & CMOSale9,705$26.22$254,502
Sep 3, 2026Maze Therapeutics, Inc. (MAZE)President, R&D & CMOSale10,295$26.24$270,111
Sep 1, 2026Maze Therapeutics, Inc. (MAZE)President, R&D & CMOSale16,141$26.36$425,512
Aug 13, 2026Maze Therapeutics, Inc. (MAZE)President, R&D & CMOSale16,142$27.61$445,621
Jul 1, 2026Maze Therapeutics, Inc. (MAZE)President, R&D & CMOSale14,609$29.90$436,865
Jun 1, 2026Maze Therapeutics, Inc. (MAZE)President, R&D & CMOSale14,853$25.66$381,112
May 14, 2026Maze Therapeutics, Inc. (MAZE)President, R&D & CMOSale15,000$26.22$393,354